Trials / Sponsors / eXIthera Pharmaceuticals
eXIthera Pharmaceuticals
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients Thrombopenia, Covid19 | Phase 2 | 2023-10-01 |
| Completed | Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects Arthroplasty, Replacement, Knee | Phase 1 | 2016-07-01 |